Close Menu

DIY mutH5N1?

The amateur biologist tinkering away in her garage is Michael Osterholm's biggest concern when it comes to the potential publication of the mutated H5N1 bird flu virus papers.

After months of debate, The New York Times reports, "a panel of scientists brought together by the World Health Organization recommended last week in favor of publishing the [mutH5N1] results." Still, it adds, "there is no word on exactly when those papers — withheld since last fall by the journals Nature and Science — will appear."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.